You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API NARATRIPTAN HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing NARATRIPTAN HYDROCHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
GlaxoSmithKline LLC	AMERGE	naratriptan hydrochloride	0173-0561	CELLULOSE, MICROCRYSTALLINE
GlaxoSmithKline LLC	AMERGE	naratriptan hydrochloride	0173-0561	CROSCARMELLOSE SODIUM
GlaxoSmithKline LLC	AMERGE	naratriptan hydrochloride	0173-0561	HYPROMELLOSE
GlaxoSmithKline LLC	AMERGE	naratriptan hydrochloride	0173-0561	LACTOSE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for NARATRIPTAN HYDROCHLORIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

NARATRIPTAN HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

NARATRIPTAN HYDROCHLORIDE drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

NARATRIPTAN HYDROCHLORIDE drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE

NARATRIPTAN HYDROCHLORIDE drug variants containing LACTOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing LACTOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

NARATRIPTAN HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

NARATRIPTAN HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

NARATRIPTAN HYDROCHLORIDE drug variants containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
GlaxoSmithKline LLC	naratriptan hydrochloride	0173-0561
>Company	>Ingredient	>NDC

NARATRIPTAN HYDROCHLORIDE drug variants not containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.